Beruflich Dokumente
Kultur Dokumente
Typhoid polysaccharide vaccine Package Leaflet: Information for the User Read all of this leaflet carefully before you receive this vaccine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This vaccine has been prescribed for you. Do not pass it on to others. If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1 What Typherix is and what it is used for 2 Before receiving Typherix 3 How Typherix is given 4 Possible side effects 5 How to store Typherix 6 Further information
424321
If you have any questions about the amount of vaccine you are being given, please speak to your doctor.
6 Further information
What Typherix contains The active substance is 25 micrograms of the Vi polysaccharide antigen, a part of the Salmonella typhi (Ty2 strain) bacterium that causes typhoid fever. The other ingredients are sodium chloride, disodium phosphate dihydrate, sodium dihydrogen phosphate dihydrate, phenol and water for injections. What Typherix looks like and contents of the pack Typherix is a clear colourless solution. Typherix is available as 0.5 ml pre-filled syringes and is available in packs of 1, 10, 50 or 100, however not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer Marketing Authorisation holder: SmithKline Beecham plc, trading as GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex, UB11 1BT Manufacturer: GlaxoSmithKline Biologicals s.a., Rixensart, Belgium. Other formats: To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:
This is a service provided by the Royal National Institute of Blind People. This leaflet was last approved in July 2009 Typherix is a registered trademark of the GlaxoSmithKline group of companies. 2009 GlaxoSmithKline group of companies